Xencor (XNCR) Current Taxes (2016 - 2026)

Xencor (XNCR) posted quarterly Current Taxes of $841000.0 for Q1 2026, down 76.57% quarter-over-quarter from $3.6 million in Q4 2025.

Xencor (XNCR) Current Taxes (2016 - 2026) Analysis & Trends

Xencor (XNCR) has reported Current Taxes for 8 consecutive years, with $841000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Current Taxes changed N/A year-over-year to $841000.0; the TTM figure through Mar 2026 stood at $841000.0 (changed N/A YoY), while the FY2025 annual figure was $3.6 million, changed N/A from the prior year.
Current Taxes fell to $841000.0 in Q1 2026 per XNCR's latest filing, from $3.6 million in the prior quarter.
Across five years, Current Taxes topped out at $5.3 million in Q4 2023 and bottomed at $388000.0 in Q3 2022.
Historically, Current Taxes has averaged $3.1 million across 5 years, with a median of $3.6 million in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Xencor	1.73 Bn	1.36 Bn	-	1.50 Mn

Download Data